Bupropion SR for Treating Smokeless Tobacco Use

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the efficacy and safety of bupropion SR for quitting tobacco in smokeless tobacco users.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mayo Clinic
• Collaborator: West Virginia University
• Treatments: Bupropion; Lobeline

Criteria

Inclusion Criteria:

• 18 years of age or older

• used ST daily for at least one year

• in good general health

• willing to complete all study procedures